Orthofix International reported $446.13M in Current Assets for its fiscal quarter ending in June of 2026.





Current Assets Change Date
Accuray USD 292.39M 11.22M Dec/2025
AngioDynamics USD 161.35M 4.69M Sep/2025
Artivion USD 371.38M 13.86M Jun/2026
AtriCure USD 345.53M 31.84M Jun/2026
Dexcom USD 4.09B 245.1M Jun/2026
EDAP TMS EUR 50.36M 6.01M Mar/2026
Globus Medical USD 2.22B 17.39M Jun/2026
Inogen USD 203.72M 594K Sep/2025
Insulet USD 1.85B 139.6M Jun/2026
Integra LifeSciences USD 1.19B 19.46M Jun/2026
J&J USD 59.77B 601M Jun/2026
Medtronic USD 24.79B 716M Mar/2026
Mesa Laboratories USD 105.63M 8.2M Dec/2025
Orthofix International USD 446.13M 15.39M Jun/2026
Plus Therapeutics USD 11.77M 6.26M Jun/2026
Smith & Nephew USD 4.39B 240M Jun/2026
STAAR Surgical USD 342.35M 29.96M Jun/2026
Stryker USD 14.42B 1.08B Jun/2026
Tandem Diabetes Care USD 804.64M 82.46M Jun/2026
Teleflex USD 1.88B 16.21M Jun/2026
Veracyte USD 574.78M 52.6M Jun/2026
Zimmer Biomet Holdings USD 5.1B 134.2M Jun/2026